학술논문
EFFICACY AND SAFETY OF LUSPATERCEPT VERSUS EPOETIN ALFA IN ERYTHROPOIESIS-STIMULATING AGENT (ESA)-NAIVE PATIENTS WITH TRANSFUSION-DEPENDENT LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS): FULL ANALYSIS OF THE COMMANDS TRIAL
Document Type
article
Author
G. Garcia-Manero; U. Platzbecker; V. Santini; A. Zeidan; P. Fenaux; R. Komrokji; J. Shortt; D. Valcarcel; A. Jonasova; S. Dimicoli-Salazar; I.S. Tiong; C.-C. Lin; J. Li; J. Zhang; A.C. Giuseppi; S. Kreitz; V. Pozharskaya; K. Keeperman; S. Rose; T. Prebet; A. Degulys; S. Paolini; T. Cluzeau; M. Della Porta
Source
Leukemia Research Reports, Vol 21, Iss , Pp 100447- (2024)
Subject
Language
English
ISSN
2213-0489
Abstract
Introduction: We report the full analysis of the COMMANDS trial assessing efficacy and safety of luspatercept versus epoetin alfa (EA) in ESA-naive patients with LR-MDS. Methods: 363 patients (aged ≥18 y, with transfusion-dependent LR-MDS, serum erythropoietin